Compass Therapeutics (CMPX) Research & Development (2019 - 2026)
Compass Therapeutics (CMPX) posted Research & Development of $19.58 million for Q2 2026, up 19.3% from $16.42 million a year earlier and up 46.2% from the prior quarter.
Powered by 
Analysis
Compass Therapeutics (CMPX) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Compass Therapeutics was $59.46 million, up 16.3% year-over-year; for FY2025, it came in at $55.97 million, up 32.2% from FY2024.
- Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
- In prior years, Compass Therapeutics' Research & Development was $42.34 million in FY2024 (+11.1%), $38.12 million in FY2023 (+27.1%), $30 million in FY2022 (+47.5%) and $20.34 million in FY2021 (+36.5%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q1 2019.
- On a year-over-year basis, Research & Development has increased in each of the last seven quarters, with growth averaging 20.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2022, with growth of 210.4%; the weakest was Q3 2023, with a decline of 9.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $13.39 million (Q1 2026), $13.67 million (Q4 2025) and $12.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Compass Therapeutics | 151.27 Mn | -597.53 Mn | - | 22.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 22.04 Mn |
| Jun 30, 2026 | 19.58 Mn |
| Mar 31, 2026 | 13.39 Mn |
| Dec 31, 2025 | 13.67 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Jun 30, 2025 | 16.42 Mn |
| Mar 31, 2025 | 13.05 Mn |
| Dec 31, 2024 | 13.04 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Jun 30, 2024 | 11.17 Mn |
| Mar 31, 2024 | 9.52 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 6.64 Mn |
| Dec 31, 2022 | 9.93 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 5.86 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 9.57 Mn |
API Access
Compass Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CMPX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CMPX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CMPX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();